Savran Technologies Inc, based in Newton, MA, is a leading company specializing in the development of non-invasive diagnostic technologies. With their unique patented micro-fluidic designs and processes, they have the ability to isolate ultra-rare cells from blood, offering a streamlined workflow, fast processing, high capture efficiency, and near-100% purity. Their technology has been successfully applied in cancer diagnostics, particularly in the detection of circulating tumor cells, as well as in prenatal diagnostics for the isolation and genetic analysis of fetal cells. Under the leadership of Dr. Cagri Savran, the founder and CEO, Savran Technologies Inc has a team of experienced professionals, including Dr. Chun-Li Chang, the Director of R&D, and Scott Posnick, the CFO. With their expertise in mechanical engineering, biomedicine, and bioinstrumentation, the company continues to innovate and develop advanced microfluidic systems for various applications in the field of non-invasive diagnostics.Generated from the website